241 related articles for article (PubMed ID: 8608530)
1. Hormone receptor status of breast tumors in black, Hispanic, and non-Hispanic white women. An analysis of 13,239 cases.
Gapstur SM; Dupuis J; Gann P; Collila S; Winchester DP
Cancer; 1996 Apr; 77(8):1465-71. PubMed ID: 8608530
[TBL] [Abstract][Full Text] [Related]
2. Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data.
Schinkel JK; Zahm SH; Jatoi I; McGlynn KA; Gallagher C; Schairer C; Shriver CD; Zhu K
Cancer Causes Control; 2014 Aug; 25(8):959-68. PubMed ID: 24839049
[TBL] [Abstract][Full Text] [Related]
3. Trends in use of contralateral prophylactic mastectomy by racial/ethnic group and ER/PR status among patients with breast cancer: A SEER population-based study.
Brown D; Shao S; Jatoi I; Shriver CD; Zhu K
Cancer Epidemiol; 2016 Jun; 42():24-31. PubMed ID: 26999400
[TBL] [Abstract][Full Text] [Related]
4. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.
Elledge RM; Clark GM; Chamness GC; Osborne CK
J Natl Cancer Inst; 1994 May; 86(9):705-12. PubMed ID: 7908990
[TBL] [Abstract][Full Text] [Related]
5. Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups.
Kurian AW; Fish K; Shema SJ; Clarke CA
Breast Cancer Res; 2010; 12(6):R99. PubMed ID: 21092082
[TBL] [Abstract][Full Text] [Related]
6. Behavioral risk factors and their relationship to tumor characteristics in Hispanic and non-Hispanic white long-term breast cancer survivors.
Abdel-Maksoud MF; Risendal BC; Slattery ML; Giuliano AR; Baumgartner KB; Byers TE
Breast Cancer Res Treat; 2012 Jan; 131(1):169-76. PubMed ID: 21822637
[TBL] [Abstract][Full Text] [Related]
7. Mediation of Racial and Ethnic Disparities in Estrogen/Progesterone Receptor-Negative Breast Cancer by Socioeconomic Position and Reproductive Factors.
Rauscher GH; Campbell RT; Wiley EL; Hoskins K; Stolley MR; Warnecke RB
Am J Epidemiol; 2016 May; 183(10):884-93. PubMed ID: 27076668
[TBL] [Abstract][Full Text] [Related]
8. Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base.
Killelea BK; Yang VQ; Wang SY; Hayse B; Mougalian S; Horowitz NR; Chagpar AB; Pusztai L; Lannin DR
J Clin Oncol; 2015 Dec; 33(36):4267-76. PubMed ID: 26598753
[TBL] [Abstract][Full Text] [Related]
9. Age-specific incidence of breast cancer subtypes: understanding the black-white crossover.
Clarke CA; Keegan TH; Yang J; Press DJ; Kurian AW; Patel AH; Lacey JV
J Natl Cancer Inst; 2012 Jul; 104(14):1094-101. PubMed ID: 22773826
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.
Parise CA; Bauer KR; Brown MM; Caggiano V
Breast J; 2009; 15(6):593-602. PubMed ID: 19764994
[TBL] [Abstract][Full Text] [Related]
11. The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999-2004.
Brown M; Tsodikov A; Bauer KR; Parise CA; Caggiano V
Cancer; 2008 Feb; 112(4):737-47. PubMed ID: 18189290
[TBL] [Abstract][Full Text] [Related]
12. The joint contribution of tumor phenotype and education to breast cancer survival disparity between Hispanic and non-Hispanic white women.
Boone SD; Baumgartner KB; Joste NE; Pinkston CM; Yang D; Baumgartner RN
Cancer Causes Control; 2014 Mar; 25(3):273-82. PubMed ID: 24337810
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer among Hispanic and non-Hispanic White women in Arizona.
Martínez ME; Nielson CM; Nagle R; Lopez AM; Kim C; Thompson P
J Health Care Poor Underserved; 2007 Nov; 18(4 Suppl):130-45. PubMed ID: 18065856
[TBL] [Abstract][Full Text] [Related]
14. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
[TBL] [Abstract][Full Text] [Related]
15. Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States.
Slattery ML; Baumgartner KB; Giuliano AR; Byers T; Herrick JS; Wolff RK
Breast Cancer Res Treat; 2011 Sep; 129(2):531-9. PubMed ID: 21475998
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of plasma HER-2/neu in African American and Hispanic women with breast cancer.
Wu Y; Khan H; Chillar R; Vadgama JV
Int J Oncol; 1999 Jun; 14(6):1021-37. PubMed ID: 10339653
[TBL] [Abstract][Full Text] [Related]
17. Racial comparison of receptor-defined breast cancer in Southern African women: subtype prevalence and age-incidence analysis of nationwide cancer registry data.
Dickens C; Duarte R; Zietsman A; Cubasch H; Kellett P; Schüz J; Kielkowski D; McCormack V
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2311-21. PubMed ID: 25143359
[TBL] [Abstract][Full Text] [Related]
18. Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients.
Dunnwald LK; Rossing MA; Li CI
Breast Cancer Res; 2007; 9(1):R6. PubMed ID: 17239243
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer characteristics and outcomes among Hispanic Black and Hispanic White women.
Banegas MP; Li CI
Breast Cancer Res Treat; 2012 Aug; 134(3):1297-304. PubMed ID: 22772379
[TBL] [Abstract][Full Text] [Related]
20. Breast Cancer Incidence Among US Women Aged 20 to 49 Years by Race, Stage, and Hormone Receptor Status.
Xu S; Murtagh S; Han Y; Wan F; Toriola AT
JAMA Netw Open; 2024 Jan; 7(1):e2353331. PubMed ID: 38277147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]